Active Lungs & Breathing Heart, Stroke & Blood

Investigation into the impact of mast cell activation on the vasculature during chronic lung diseases

In plain English

AI plain-English summary

Mast cells—immune cells best known for triggering allergic reactions—are tearing apart the tiny blood vessels that keep lungs healthy. One in five people in the UK live with a chronic lung disease such as asthma or COPD, and that number is rising. While inflammation in the airways gets most of the attention, the dense network of blood vessels that supply oxygen and remove waste from lung tissue is quietly damaged during chronic disease. The researcher has already shown that mast cells can disrupt pericytes—the cells that wrap around blood vessels and keep them stable—in other parts of the body. This project asks whether the same thing happens in the lungs, where both mast cells and pericytes are abundant. The project combines mouse models, human tissue samples, spatial transcriptomics, and 3D imaging to track how overactive mast cells cause pericyte loss and what that does to lung blood vessel function. If the work identifies specific mast-cell-derived factors—such as proteases—that drive this damage, those molecules could become targets for new drugs. The goal is to prevent pericyte dysfunction and, ultimately, slow or stop the vascular damage that worsens chronic lung disease.

View original technical description
Chronic lung diseases such as asthma and COPD are a major health problem in the UK with an estimated 1/5 people impacted by one form of lung disease and this number is predicted to increase in the next decade. One underestimated impact of respiratory disease is the effect of chronic inflammation on the crucial network of blood vessels in the lungs. During my previous projects and fellowship, I discovered that mast cells (MCs), a type of immune cell, play a vital role during vascular inflammation and can modulate function of pericytes, the structural components of the vascular wall. The importance of this interaction in the lungs, where MCs and pericytes are abundant, remains to be investigated. My proposed project, combining mouse models, human samples, spatial transcriptomics, and 3D analysis of blood vessels will shed new light on this important question. I will investigate how the hyperactivation of MCs leads to pericyte loss, and how this impacts lung vascular function. Furthermore, this transdisciplinary proposal will identify MC-derived factors such as proteases as potential therapeutic targets. In summary, my project will develop strategies to prevent pericyte dysfunction and further prevent respiratory and vascular disorders during chronic lung diseases.

View the original record at the funder ↗

Researchers

Regis Joulia (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Pericyte mobilisation and functional plasticity in chronic allergic airway disease
Cellular dynamics in chronic lung disease: the neglected B cell axis
Understanding aberrant cell signalling mechanisms in chronic lung disease
Mast cell-mediated regulation of immune responses in health and disease
Cathepsin S inhibition as a treatment for lung inflammation and lung damage in Chronic Lung Disease

Original classification

Career Development Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.